Search results for "Somatomedin"

showing 9 items of 9 documents

Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma

2020

Contains fulltext : 235640.pdf (Publisher’s version ) (Closed access) Genome-wide association studies (GWAS) of esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), have uncovered significant genetic components of risk, but most heritability remains unexplained. Targeted assessment of genetic variation in biologically relevant pathways using novel analytical approaches may identify missed susceptibility signals. Central obesity, a key BE/EAC risk factor, is linked to systemic inflammation, altered hormonal signaling and insulin-like growth factor (IGF) axis dysfunction. Here, we assessed IGF-related genetic variation and risk of BE and EAC. Principal component analys…

0301 basic medicineOncologyMaleCancer Researchmedicine.medical_specialtyEsophageal NeoplasmsMedizinSingle-nucleotide polymorphismGenome-wide association studyBiologyAdenocarcinomaPolymorphism Single NucleotideReceptor IGF Type 103 medical and health sciencesBarrett Esophagus0302 clinical medicineRisk FactorsSomatomedinsInternal medicineGenetic variationmedicineBiomarkers TumorSNPHumansGenetic Predisposition to DiseaseRisk factorGerm-Line MutationCancer Biomarkers and Molecular EpidemiologyInsulin-like growth factor 1 receptorGenetic associationAgedGeneral MedicineMiddle Agedmedicine.diseaseRenal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11]030104 developmental biology030220 oncology & carcinogenesisBarrett's esophagusFemaleHuman medicineCarrier ProteinsGenome-Wide Association StudySignal TransductionCarcinogenesis
researchProduct

Drosophila and humans share similar mechanisms of insulin secretion

2017

Drosophila and humans share similar mechanisms of insulin secretion

0301 basic medicineanimal structures[SDV]Life Sciences [q-bio][SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyfungiGeneral MedicineBiologybiology.organism_classificationSomatomedinGeneral Biochemistry Genetics and Molecular Biology3. Good healthCell biology03 medical and health sciences030104 developmental biologyFeeding behavior[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]LeucineDrosophila melanogasterInsulin secretion[SDV.AEN]Life Sciences [q-bio]/Food and NutritionSecretory pathwayDrosophila ProteinComputingMilieux_MISCELLANEOUS
researchProduct

Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical…

2014

Abstract Purpose: Mammalian target of rapamycin (mTOR) inhibition activates compensatory insulin–like growth factor receptor (IGFR) signaling. We evaluated the ridaforolimus (mTOR inhibitor) and dalotuzumab (anti-IGF1R antibody) combination. Experimental Design: In vitro and in vivo models, and a phase I study in which patients with advanced cancer received ridaforolimus (10–40 mg/day every day × 5/week) and dalotuzumab (10 mg/kg/week or 7.5 mg/kg/every other week) were explored. Results: Preclinical studies demonstrated enhanced pathway inhibition with ridaforolimus and dalotuzumab. With 87 patients treated in the phase I study, main dose-limiting toxicities (DLT) of the combination were p…

AdultCancer ResearchPhases of clinical researchBreast NeoplasmsPharmacologyAntibodies Monoclonal HumanizedArticleReceptor IGF Type 1Ridaforolimuschemistry.chemical_compoundBreast cancerIn vivoAntineoplastic Combined Chemotherapy ProtocolsMedicineAnimalsHumansPI3K/AKT/mTOR pathwayInsulin-like growth factor 1 receptorAgedSirolimusDalotuzumabbusiness.industryTOR Serine-Threonine KinasesAntibodies MonoclonalReceptors SomatomedinMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysOncologychemistryMonoclonalbusinessSignal TransductionClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.

1986

This study examined the effects of the long-acting selective mini somatostatin analogue (SMS) 201-995 in two acromegalic patients who were treated for 3 and 6 months, respectively. During treatment the mean growth hormone levels (25.3 and 20.8 ng/ml vs 5.9 and 10.6 ng/ml) and somatomedin C levels (6.2 and 6.2 IU/ml vs 3.3 and 3.8 IU/ml) decreased and the patients reported an improvement in their symptoms. The main side effect was an increase in stool fat excretion which did exceed the normal range (less than 7 g/day) in one patient. Five acromegalics who received 2 X 50 micrograms SMS 201-995/day for 5 days showed a significant increase of stool fat excretion (1.7 vs 3.5 g/day; p less than …

Adultmedicine.medical_specialtyLong term treatmentSide effectAntineoplastic AgentsOctreotideExcretionInternal medicineDrug DiscoveryAcromegalyMedicineHumansPituitary NeoplasmsGenetics (clinical)Glycated Hemoglobinbusiness.industryAdenoma AcidophilGeneral MedicineGlucose Tolerance TestMiddle Agedmedicine.diseaseSomatomedinCombined Modality TherapyLong-Term CareSomatostatin AnalogueSomatostatinEndocrinologyGrowth HormoneAcromegalyMolecular MedicineFemaleHemoglobinNeoplasm Recurrence LocalbusinessSomatostatinKlinische Wochenschrift
researchProduct

Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone t…

2007

Background and aims Cardiomyocyte apoptosis (CA) is a common feature of end-stage heart failure. We examined whether CA is associated with cardiac dysfunction and remodelling in heart failure due to dilated cardiomyopathy and studied the effect of human growth hormone (hGH) on CA. Methods and results We studied 38 patients, included in a phase III multi-center, randomised, double-blind and placebo-controlled trial of biosynthetic hGH treatment in dilated cardiomyopathy, at baseline and after 14 weeks treatment. Twenty-six patients received hGH and 12 received placebo. CA was quantified in endomyocardial biopsies using the TUNEL assay. CA correlated with left ventricular size (r=0.43, p=0.00…

Cardiomyopathy DilatedMalemedicine.medical_specialtyHeart VentriclesApoptosisPlaceboVentricular Dysfunction LeftInterquartile rangeSomatomedinsInternal medicinemedicineHumansMyocytes CardiacTUNEL assayEjection fractionbusiness.industryHuman Growth HormoneDilated cardiomyopathyStroke VolumeMiddle Agedmedicine.diseaseFas receptorImmunohistochemistryGrowth hormone treatmentEndocrinologyHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEuropean journal of heart failure
researchProduct

Insulin-like growth factors counteract the effect of interleukin 1 beta on type II phospholipase A2 expression and arachidonic acid release by rabbit…

1994

International audience; Interleukin 1 beta was found to stimulate arachidonic acid release, and the synthesis and secretion of type II phospholipase A2 by rabbit articular chondrocytes in vitro. Interleukin 1 beta had no effect on the level of cytosolic phospholipase A2 mRNA. Insulin-like growth factors, which help stabilize the cartilage matrix, reduced the effect of interleukin 1 beta on type II phospholipase A2 activity and mRNA level, and decreased the Interleukin 1 beta-stimulated arachidonic acid release to the basal values. This suggests that type II phospholipase A2 plays a key role in arachidonic acid release from rabbit articular chondrocytes and that insulin-like growth factors c…

Cartilage Articularmedicine.medical_specialtymedicine.medical_treatmentBiophysicsIn Vitro TechniquesBiochemistryChondrocytePhospholipases AInterleukin 1βInsulin-like growth factorchemistry.chemical_compoundPhospholipase A2[ CHIM.ORGA ] Chemical Sciences/Organic chemistryPhospholipase A2Structural BiologyInsulin-Like Growth Factor IIInternal medicineGeneticsmedicineAnimalsInsulin-like growth factorRNA MessengerInsulin-Like Growth Factor IMolecular BiologyArachidonic Acidbiology[CHIM.ORGA]Chemical Sciences/Organic chemistryArthritisInterleukinCell Biology[CHIM.ORGA] Chemical Sciences/Organic chemistryChondrocyteSomatomedinPhospholipases A2Endocrinologymedicine.anatomical_structureCytokinechemistryInsulin-like growth factor 2biology.proteinArachidonic acidRabbitsInterleukin-1
researchProduct

The Divergent Effect of Insulin-Like Growth Factor Binding Protein (IGFBP) - 1 on IGF-induced Steroidogenesis in Bovine Adrenocortical Cells is not d…

2007

In previous studies we have shown that insulin-like growth factor (IGF)-II stimulates basal as well as ACTH-induced cortisol secretion from bovine adrenocortical cells more potently than IGF-I. The steroidogenic effect of both, IGF-I and IGF-II, is mediated through the IGF-I receptor and modified by locally produced IGF binding proteins. Further studies demonstrate that bovine adrenocortical cells do synthesize IGFBP-1 to -4 and that their secretion is regulated differentially by IGFs and ACTH. Since IGFBP-1 selectively is induced 3- to 4- fold by ACTH, the aim of the following studies was to evaluate the effect of IGFBP-1 on IGF-induced cortisol secretion from bovine adrenocortical cells i…

Cortisol secretionmedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiologyCulture Media Serum-FreeInsulin-like growth factor-binding proteinInsulin-like growth factorEndocrinologyAdrenocorticotropic HormoneSomatomedinsInternal medicineInternal MedicinemedicineAnimalsPhosphorylationReceptorCells CulturedAdrenal cortexGrowth factorGeneral MedicineLigand (biochemistry)Insulin-Like Growth Factor Binding Protein 1KineticsEndocrinologymedicine.anatomical_structureInsulin-like growth factor 2Adrenal Cortexbiology.proteinCattlehormones hormone substitutes and hormone antagonistsExperimental and Clinical Endocrinology & Diabetes
researchProduct

Evaluation of occupational physical load during 6-month international crisis management operation

2018

Objectives Generally, operational military duties are associated with a variety of stressors, such as prolonged physical activity (PA). However, limited information is available on the occupational workload or changes in PA during international military operations. Thus, the aim of the study was to investigate the changes in body composition, stress biomarkers, PA, and heart rate (HR) responses of 79 male soldiers during a 6-month international crisis management operation. Material and Methods Measurements were conducted 3 times in South-Lebanon during the operation. Body composition was assessed by the bioelectrical impedance method. Blood samples were analyzed for serum testosterone, sex-…

MaleSalivaHydrocortisone0211 other engineering and technologieslcsh:Medicine02 engineering and technologyworkload0302 clinical medicineSex hormone-binding globulinHeart RateSex Hormone-Binding GlobulinTestosteronesotilaatLebanonta315TestosteroneFinlandphysical exertionbiologyGeneral Medicineta3142Body CompositionBioelectrical impedance analysisWorking environmentAdultmedicine.medical_specialtyfyysinen rasitustyömäärä03 medical and health sciencesSomatomedinsStress PhysiologicalInternal medicineHeart ratemedicineaccelerometryHumanssotilaslääketiedeExertionSalivaExercise021110 strategic defence & security studiesbusiness.industrytyöterveysrauhanturvaajatlcsh:RPublic Health Environmental and Occupational Health030229 sport sciencesfyysinen kuormittavuusEndocrinologyPhysical loadsotilashenkilöstöoccupational healthbiology.proteinPhysical therapymilitary personnelalpha-Amylasesbusinessmilitary medicineInternational Journal of Occupational Medicine and Environmental Health
researchProduct

Radioimmunological determination of somatomedin B in healthy children and patients with HGH deficiency

1979

In 192 boys and girls, aging from 1 month to 16 years, serum somatomedin B levels were performed by radioimmunoassay of Kabi Inc., slightly modified. In girls the mean value increased from the 1 st. month at the end of the second year of live from 10.5±6.2 to 19.2±9.2 mg/1, in boys at the same time from 10±3.9 to 20.3±6.2 mg/1. The values decreased in girls in the following years up to the age of 14-16 years to 13.7±7.5 mg/1; in the boys to 11.5±4.2mg/1. The beginning of the decrease was in girls two years earlier than in boys. To these values of normal children were compared the values of 8 patients with HGH deficiency. The mean of these cildren was 4.2 mg/1, significantly below the values…

medicine.medical_specialtyEndocrinologySomatomedin Bbusiness.industryInternal medicinePediatrics Perinatology and Child HealthNormal childrenMean valuemedicineRadioimmunoassaybusinessPediatric Research
researchProduct